Advisors Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $220K | Buy |
+971
| New | +$173K | ﹤0.01% | 1143 |
|
|
2025
Q4 | – | Sell |
-2,627
| Closed | -$411K | – | 1460 |
|
|
2025
Q3 | $411K | Sell |
2,627
-41
| -2% | -$6.51K | 0.01% | 1007 |
|
|
2025
Q2 | $405K | Sell |
2,668
-90
| -3% | -$12K | 0.01% | 985 |
|
|
2025
Q1 | $415K | Sell |
2,758
-58
| -2% | -$9.72K | 0.01% | 973 |
|
|
2024
Q4 | $520K | Sell |
2,816
-610
| -18% | -$118K | 0.01% | 915 |
|
|
2024
Q3 | $675K | Sell |
3,426
-167
| -5% | -$34.7K | 0.01% | 839 |
|
|
2024
Q2 | $742K | Buy |
3,593
+234
| +7% | +$53K | 0.01% | 797 |
|
|
2024
Q1 | $910K | Buy |
3,359
+1,126
| +50% | +$269K | 0.02% | 758 |
|
|
2023
Q4 | $528K | Sell |
2,233
-1,169
| -34% | -$230K | 0.01% | 883 |
|
|
2023
Q3 | $667K | Sell |
3,402
-90
| -3% | -$18.5K | 0.01% | 827 |
|
|
2023
Q2 | $734K | Sell |
3,492
-3,107
| -47% | -$618K | 0.01% | 836 |
|
|
2023
Q1 | $1.33M | Sell |
6,599
-139
| -2% | -$31.5K | 0.03% | 655 |
|
|
2022
Q4 | $1.47M | Sell |
6,738
-5,105
| -43% | -$1.11M | 0.03% | 599 |
|
|
2022
Q3 | $2.33M | Sell |
11,843
-4,112
| -26% | -$888K | 0.05% | 454 |
|
|
2022
Q2 | $3.41M | Sell |
15,955
-5,523
| -26% | -$1.35M | 0.06% | 331 |
|
|
2022
Q1 | $6.1M | Sell |
21,478
-527
| -2% | -$163K | 0.09% | 227 |
|
|
2021
Q4 | $8.29M | Buy |
22,005
+52
| +0.2% | +$20.2K | 0.12% | 177 |
|
|
2021
Q3 | $9.06M | Buy |
21,953
+2,385
| +12% | +$991K | 0.14% | 144 |
|
|
2021
Q2 | $7.24M | Buy |
19,568
+4,595
| +31% | +$1.53M | 0.1% | 204 |
|
|
2021
Q1 | $4.34M | Sell |
14,973
-196
| -1% | -$54.5K | 0.07% | 291 |
|
|
2020
Q4 | $3.79M | Buy |
15,169
+3,271
| +27% | +$779K | 0.06% | 325 |
|
|
2020
Q3 | $2.69M | Buy |
11,898
+3,088
| +35% | +$641K | 0.05% | 359 |
|
|
2020
Q2 | $1.54M | Buy |
8,810
+2,599
| +42% | +$415K | 0.03% | 556 |
|
|
2020
Q1 | $784K | Sell |
6,211
-1,337
| -18% | -$201K | 0.02% | 687 |
|
|
2019
Q4 | $1.15M | Sell |
7,548
-729
| -9% | -$101K | 0.02% | 708 |
|
|
2019
Q3 | $1.1M | Sell |
8,277
-4,731
| -36% | -$634K | 0.02% | 721 |
|
|
2019
Q2 | $1.85M | Sell |
13,008
-878
| -6% | -$119K | 0.03% | 576 |
|
|
2019
Q1 | $2.02M | Buy |
13,886
+2,478
| +22% | +$326K | 0.04% | 540 |
|
|
2018
Q4 | $1.29M | Sell |
11,408
-155
| -1% | -$19.4K | 0.03% | 676 |
|
|
2018
Q3 | $1.56M | Sell |
11,563
-123
| -1% | -$15.2K | 0.03% | 690 |
|
|
2018
Q2 | $1.31M | Buy |
11,686
+3,396
| +41% | +$367K | 0.02% | 747 |
|
|
2018
Q1 | $884K | Sell |
8,290
-1,923
| -19% | -$207K | 0.01% | 883 |
|
|
2017
Q4 | $1.12M | Sell |
10,213
-1,239
| -11% | -$135K | 0.02% | 803 |
|
|
2017
Q3 | $1.24M | Buy |
11,452
+11,129
| +3,446% | +$1.14M | 0.02% | 776 |
|
|
2017
Q2 | $33K | Buy |
+323
| New | +$29.7K | ﹤0.01% | 1462 |
|
|
2017
Q1 | – | Sell |
-16,941
| Closed | -$1.29M | – | 1596 |
|
|
2016
Q4 | $1.29M | Sell |
16,941
-2,499
| -13% | -$190K | 0.02% | 805 |
|
|
2016
Q3 | $1.62M | Sell |
19,440
-16,202
| -45% | -$1.36M | 0.03% | 694 |
|
|
2016
Q2 | $2.94M | Sell |
35,642
-4,196
| -11% | -$346K | 0.05% | 533 |
|
|
2016
Q1 | $3.02M | Sell |
39,838
-18,373
| -32% | -$1.36M | 0.05% | 514 |
|
|
2015
Q4 | $4.68M | Sell |
58,211
-6,818
| -10% | -$492K | 0.07% | 378 |
|
|
2015
Q3 | $4.13M | Buy |
65,029
+3,906
| +6% | +$280K | 0.07% | 405 |
|
|
2015
Q2 | $4.3M | Buy |
61,123
+6,448
| +12% | +$477K | 0.06% | 432 |
|
|
2015
Q1 | $4.33M | Buy |
54,675
+14,635
| +37% | +$1.08M | 0.06% | 420 |
|
|
2014
Q4 | $2.55M | Buy |
40,040
+7,886
| +25% | +$494K | 0.03% | 563 |
|
|
2014
Q3 | $1.92M | Buy |
32,154
+6,775
| +27% | +$388K | 0.03% | 637 |
|
|
2014
Q2 | $1.36M | Buy |
25,379
+9,965
| +65% | +$547K | 0.02% | 726 |
|
|
2014
Q1 | $930K | Buy |
15,414
+5,776
| +60% | +$337K | 0.01% | 796 |
|
|
2013
Q4 | $511K | Sell |
9,638
-909
| -9% | -$45.7K | 0.01% | 955 |
|
|
2013
Q3 | $488K | Sell |
10,547
-1,874
| -15% | -$86K | 0.01% | 903 |
|
|
2013
Q2 | $510K | Buy |
+12,421
| New | +$532K | 0.01% | 849 |
|
Other funds holding CRL
AI
Advisors Asset Management's CRL Position: Q2 2026 in Review
Advisors Asset Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 971 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #1143 among its holdings. This is a return to the name: Advisors Asset Management previously reported a position in CRL as recently as Q3 2025.
Advisors Asset Management first reported a position in CRL in Q2 2013 and has held it in 50 quarters since. The position peaked at $9.06M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Advisors Asset Management held 971 shares of Charles River Laboratories worth $220K as of Q2 2026.
- Charles River Laboratories was a new Advisors Asset Management position in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1143 holding.
- Advisors Asset Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 50 quarters since.
- Advisors Asset Management's Charles River Laboratories position peaked at $9.06M in Q3 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.